AKT1 and non-small cell lung carcinoma: Therefore, it can be inferred that DHA might abrogate immunity escaping of NSCLC through inhibiting the PD-L1 expression via inhibiting its upstream inflammatory signaling pathways, PI3K/AKT, STAT3, and NF-ƘB.